Bright Minds Biosciences Inc. (DRUG) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bright Minds Biosciences ...

    NASDAQ: DRUG · Real-Time Price · USD
    46.56
    4.39 (10.41%)
    At close: Sep 11, 2025, 12:10 PM

    Bright Minds Biosciences Cash Flow Statement

    Financials in CAD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Net Income
    		 -2.8M -7.37M -14.96M -8.65M
    Depreciation & Amortization
    		 73.36K 72.45K 6.04K n/a
    Stock-Based Compensation
    		 839.77K 1.15M 875.06K 880.62K
    Other Working Capital
    		 39.81K -941.72K 771.94K 416.23K
    Other Non-Cash Items
    		 -1.18K 65.1K -229.57K 144.76K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 39.81K -941.72K 726.31K 306.08K
    Operating Cash Flow
    		 -1.85M -7.02M -13.59M -7.32M
    Capital Expenditures
    		 n/a 5.00 n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a
    Debt Repayment
    		 -89.73K -86.11K -7.16K n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 302.00 1.06M 1.17M -1.69M
    Financial Cash Flow
    		 810.57K 2.19M 5.2M 26.06M
    Net Cash Flow
    		 -1.03M -4.88M -8.13M 18.96M
    Free Cash Flow
    		 -1.85M -7.02M -13.59M -7.32M

    Add to Watchlist